Daily News header
Press Release

Altair Nanotechnologies Begins Manufacturing of High-Power Lithium Ion Battery Cells and Announces New Test Results

Batteries Perform at 90 Percent of Capacity at Extreme Temperatures

Altair Nanotechnologies, Inc. (NASDAQ: ALTI) today announced that its facility in Anderson, Indiana has begun manufacturing and testing the first batch of lithium ion battery cells manufactured at that facility utilizing its nano-structured electrode materials. The Anderson facility is a rapid design, prototyping and applications lab for high power, lithium ion cells, batteries and battery packs.

In the latest testing of its nano-structured battery cells, Altairnano has demonstrated that 90 percent of room temperature charge retention has been achieved at minus 30°C. Recharge at this temperature is unachievable in conventional lithium batteries. In addition, conventional lithium ion batteries have the potential to suffer from thermal runaway issues potentially leading to catastrophic battery failure at temperatures above 130°C. Lithium ion batteries utilizing Altairnano's nano-structured lithium titanate spinel electrodes do not experience thermal runaway at temperatures below 250°C, significantly improving the safety performance of the batteries.

This performance characteristic as well as the batteries other attributes of rapid charge and discharge cycles, extended cycle life and environmental friendliness should be of interest in applications requiring performance at temperature extremes, such as in the aerospace and military markets.

To read the complete release at NewsBlaze,
Altair Nanotechnologies Begins Manufacturing of High-Power Lithium Ion Battery Cells and Announces New Test Results,
Click here

Related Marketwired Releases News

WestBond Enterprises Corporation is pleased to announce that it has appointed Peter R. Toigo to its board of directors.
EON Reality, the world's leading interactive 3D software provider, and Vision 3 Experiential , an industry frontrunner in multi-media content and technology for next generation film production, theme parks and museums, today announced an exclusive ...
Prima BioMed Ltd today announced that the abstract titled 'Clinical study of autologous dendritic cell therapy targeting mucin 1 for treatment of ovarian cancer patients in first remission' has been selected by the European Cancer Congress ...
Rick Moranis' My Mother's Brisket & Other Love Songs in Stores Now
CompareNetworks, Inc., a leading provider of media and platform products in web and mobile formats for the scientific and healthcare industries, announced today they have acquired scrazzl Ltd., a technology platform that links scientific products ...
Orezone Gold Corporation announces that it intends to shift the focus of the Bombore Feasibility Study in order to review and reassess the lower capital cost heap leach scenario outlined in the August 2011 Preliminary Economic Assessment . The ...

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2013 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site